Pfizer stock trades at INR 4,025.50 after India drug crackdown
Published on 09/23/2026 at 19:59 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Pfizer stock stood at INR 4,025.50 on the NSE on September 23, 2026, giving Pfizer Limited a market capitalization of INR 184.157 billion. The immediate company issue is product quality, after Economic Times reported on September 23, 2026, that Pfizer removed affected batches and is cooperating with authorities.
Quality scrutiny meets stable growth
The Karnataka FDA canceled 16 drug licenses and suspended eight others after a raid uncovered an operation repacking low-cost medicines as branded products, including Pfizer products, according to Economic Times. Pfizer said patient safety and product quality remain priorities, putting distribution controls alongside financial performance.
The latest reported quarter offers a measurable counterpoint. In Q1 FY27, revenue from operations reached INR 6.5317 billion, up 8.3 percent from INR 6.0305 billion in Q1 FY26, while standalone net profit rose 6.6 percent to INR 2.0447 billion from INR 1.9175 billion, as reported by Sahi.
Minipress exit adds cash support
Pfizer Limited discontinued the marketing, distribution and sale of Minipress XL in India on September 7, 2026, after Pfizer Inc. stopped manufacturing the cardiovascular medicine. The Indian company will receive a USD 13.9 million lump-sum transition payment, according to Sahi.
The payment is separate from operating revenue, so it should be assessed as a one-time cash benefit rather than recurring product growth. Pfizer says its Indian portfolio covers more than 150 products across 15 therapeutic areas and four business categories, according to its investor relations page.
Stock remains below its yearly high
At INR 4,025.50 on September 23, 2026, Pfizer stock was up 0.67 percent for the session. The price stood INR 70.00 above its 52-week low of INR 3,955.50 and 27.84 percent below its 52-week high of INR 5,578.50, leaving product execution and recurring sales as the key operating measures.
Pfizer Limited market profile
- Company: Pfizer Limited
- Ticker: PFIZER
- Trading venue: NSE
- Price (as of September 23, 2026, 3:30 p.m. IST): INR 4,025.50
- Market capitalization: INR 184.157 billion as of September 23, 2026
- 52-week range: INR 3,955.50-5,578.50 as of September 23, 2026
- Sector / Industry: Healthcare / Drug Manufacturers - General
